Interesting and frustrating.
Any knowledge of how an insurance company can deny and say "investigational" when it was FDA approved over 6 years ago? At what point do they switch off "investigational" and consider approving a device? Is there any logic to making that decision, or is there absolutely nothing concrete? Sent my 4th appeal, and waiting on my 4th denial right now, but hoping, by some miracle, I've sent my pre-authorization company (Med-Cert) the studies that prove ADR is no longer investigational. Then I'll probably have to move to the next step of battling the insurance company themselves, even if pre-authorized!
Ready to head to the UK....
__________________
Joey Sue - 50 years old
9/28/2011: Hybrid STALIF TT interbody fusion at L5-S1 and M6-L ADR L4-5 with Nick Boeree, UK - forever grateful to you Nick! Still doing great.
Prior to the fix: Severe DDD L4-5 and L5-S1 with moderate facet degen at L5-S1, but only mild facet degeneration at L4-5.
http://healthyback2011.blogspot.com/
|